Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
03/2010
03/24/2010CN100595208C Production of sulfating fibroin protein and its use in anticoagulant
03/23/2010US7683164 Nucleic acid derivatives
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
03/23/2010US7683038 Such as gellan, carboxymethylcellulose, pectic acid, pectin and hyaluronic acid derivativesl; for use in the pharmaceutical, biomedical, surgical and healthcare fields
03/23/2010US7683037 Myocardial perfusion imaging method
03/23/2010US7682623 Pharmaceutical composition for topical application
03/23/2010CA2372994C Implantable gel compositions and method of manufacture
03/23/2010CA2360795C Therapeutic compositions containing glutathione analogs
03/23/2010CA2353523C Allo and auto-reactive t-cell epitopes
03/18/2010WO2010030983A2 Pyrazole carboxamide inhibitors of factor xa
03/18/2010WO2010029561A1 A process for preparation of rosuvastatin acetonide calcium
03/18/2010WO2010029453A1 Composition of thrombolytic agent and anti thrombosis and also its production method
03/18/2010WO2010029185A1 Oligosaccharide compounds for use in mobilising stem cells
03/18/2010WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
03/18/2010WO2009147178A3 Substituted pyridin-2-ylmethylsulphinyl-1h-benzimidaz0les for use in the treatment of brain edema
03/18/2010US20100069456 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
03/18/2010US20100069408 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
03/18/2010US20100069386 Modulators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto
03/18/2010US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/18/2010US20100069350 New Pyridine Analogues III
03/18/2010US20100068242 Medical Devices for Localized Drug Delivery
03/18/2010US20100068215 Use of GDF traps to increase red blood cell levels
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068173 Recombinant Human Albumin-Interleukin-11 Fusion Protein With Long-Lasting Biological Effects
03/18/2010CA2736370A1 Pyrazole carboxamide inhibitors of factor xa
03/18/2010CA2734309A1 Preparation and usage of a pharmaceutical composition containing ferulic acid and matrine compounds
03/18/2010CA2679041A1 Recombinant human blood coagulation factor viii protein, composition, use of a recombinant factor viii protein, use of a composition, method of obtaining a recombinant human bloodcoagulation factor viii protein and use thereof
03/17/2010EP1924270B1 Iron (iii) complex compounds for orally treating iron deficiency in patients with chronic inflammatory intestinal diseases
03/17/2010EP1663177B1 Topical preparations comprising a hydrophilic carrier and a silicone matrix
03/17/2010EP1347955B1 New mandelic acid derivatives and their use as throbin inhibitors
03/17/2010CN101675058A Process for production of prasugrel hydrochloride having high purity
03/17/2010CN101674805A High concentration factor vii polypeptide formulations comprising an aromatic preservative and an antioxidant
03/17/2010CN101671401A Sulfonated 6-amino-6-deoxy-chitosan and preparation method thereof
03/17/2010CN101671341A Preparation method of iron chlorophyll extract
03/17/2010CN101670106A Natural activator of soluble guanylate cyclase
03/17/2010CN101670077A Attenuated compatibility formula of minor Chinese thorowax root decoction
03/17/2010CN101670069A Medicament for treating leukopenia
03/17/2010CN101670025A Ginseng cancer recovery medicinal powder
03/17/2010CN101670017A Medicine combination for tonifying blood and preparation method thereof
03/17/2010CN101669988A Extraction process of clerodendranthus spicatus
03/17/2010CN101669978A Buffer-contained Chinese traditional medicine panax notoginseng saponins
03/17/2010CN101669970A Method for microwave extracting fat-soluble toad venom by using skin of Bufo bufo gargarizans
03/17/2010CN101669954A Ferrous fumarate folic acid dispersible tablet and preparation method thereof
03/17/2010CN101669937A Composition of ginkgolide and ganglioside and preparation method thereof
03/17/2010CN101669918A Aspirin double-releasing preparation and preparation method thereof
03/17/2010CN101669904A Epoprostanol lipid nanoparticle and preparation method thereof
03/17/2010CN101669624A Chinese medicinal assorted Chinese herbal tea with function of improving woman anemia and preparation method thereof
03/17/2010CN100594211C 4-methoxy-1,3-phenyl disubstituted amide derivative
03/17/2010CN100594037C Complement receptor 2 targeted complement modulators
03/17/2010CN100594027C Percutaneous medicine of strychnine, toxiferine, securinine and salt thereof
03/16/2010US7678918 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
03/16/2010US7678790 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents
03/16/2010US7678573 Using plug flow bioreactor system which mimics bone marrow microenvironment for propagation and maintenance of stromal cells
03/16/2010CA2510519C Condensed furan compounds
03/16/2010CA2422216C Method for the production of vitamin k-dependent proteins
03/16/2010CA2395121C Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
03/16/2010CA2390590C Adenosine receptor antagonists and methods of making and using the same
03/16/2010CA2376986C Method for purification of proteins
03/16/2010CA2372575C Bradykinin receptor antagonists
03/16/2010CA2200054C Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/11/2010WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity
03/11/2010WO2010026766A1 Agent for treating myelofibrosis
03/11/2010WO2009095646A3 Peptides from factor viii
03/11/2010US20100063153 Anti-cholesterolemic compounds and methods of use
03/11/2010US20100063144 Compounds and uses thereof
03/11/2010US20100063113 Novel pharmaceutical salts and polymorphs of a factor xa inhibitor
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063048 Remedy for angiospasm accompanying subarachnoid hemorrhage containing thrombin receptor antagonist as the active ingredient
03/11/2010US20100063043 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics
03/11/2010US20100062986 Method to treat blood cell depletion
03/11/2010US20100062983 Use of Factor VIIa or Factor VIIa equivalents for treating late complications of trauma
03/11/2010US20100062981 Use of fibrinogen as a prophylactic treatment to prevent bleeding during and after surgery and as a biomarker to identify patient with an increased risk for excessive bleeding and blood transfusion
03/11/2010US20100062468 Methods and products related to low molecular weight heparin
03/11/2010US20100062058 Delayed Release Formulations for Oral Administration of a Polypeptide Therapeutic Agent and Methods of Using Same
03/11/2010US20100061989 Method of treatment and prophylaxis
03/11/2010US20100061985 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
03/11/2010CA2735709A1 Agent for treating myelofibrosis
03/10/2010EP2161282A1 Peptide analogues of PACAP
03/10/2010EP2160411A1 Anti-vpac1 antibodies and their uses
03/10/2010EP2160187A1 Spiroindalones
03/10/2010EP1751113B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/10/2010EP1544293B1 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same
03/10/2010EP1114061B1 FACTOR VIIa INHIBITORS
03/10/2010CN101664388A transnasal transport/immunisation with highly adaptable carriers
03/09/2010US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
03/09/2010US7674775 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants
03/09/2010CA2399813C Indol-3-yl derivatives
03/09/2010CA2379282C Amido spiropiperidines promote the release of growth hormone
03/09/2010CA2308904C Process for the inactivation of viruses
03/09/2010CA2159702C High molecular and low molecular fractions of von willebrand factor
03/04/2010WO2010024258A1 Ring-fused azole derivative having pi3k-inhibiting activity
03/04/2010WO2010022734A1 Treatment of thrombocytopenia
03/04/2010WO2010022553A1 An endogenous short hairpin rna and the use of the same
03/04/2010WO2008155658A3 Variegin from amblyomma variegatum is a direct thrombin inhibitor
03/04/2010US20100056464 Compounds, compositions and methods of using same for modulating uric acid levels
03/04/2010US20100056452 Angiogenesis-promoting substrate
03/04/2010US20100055067 Perfluorocarbon conjugate as a blood substitute
03/04/2010CA2734779A1 Treatment of thrombocytopenia
03/03/2010EP1505973B1 Combinations for treating multiple myeloma
1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 671